Unknown

Dataset Information

0

A genome-wide enrichment screen identifies NUMA1-loss as a resistance mechanism against mitotic cell-death induced by BMI1 inhibition.


ABSTRACT: BMI1 is a core protein of the polycomb repressive complex 1 (PRC1) that is overexpressed in several cancer types, making it a promising target for cancer therapies. However, the underlying mechanisms and interactions associated with BMI1-induced tumorigenesis are often context-dependent and complex. Here, we performed a drug resistance screen on mutagenized human haploid HAP1 cells treated with BMI1 inhibitor PTC-318 to find new genetic and mechanistic features associated with BMI1-dependent cancer cell proliferation. Our screen identified NUMA1-mutations as the most significant inducer of PTC-318 cell death resistance. Independent validations on NUMA1-proficient HAP1 and non-small cell lung cancer cell lines exposed to BMI1 inhibition by PTC-318 or BMI1 knockdown resulted in cell death following mitotic arrest. Interestingly, cells with CRISPR-Cas9 derived NUMA1 knockout also showed a mitotic arrest phenotype following BMI1 inhibition but, contrary to cells with wildtype NUMA1, these cells were resistant to BMI1-dependent cell death. The current study brings new insights to BMI1 inhibition-induced mitotic lethality in cancer cells and presents a previously unknown role of NUMA1 in this process.

SUBMITTER: Gisler S 

PROVIDER: S-EPMC7188281 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

A genome-wide enrichment screen identifies NUMA1-loss as a resistance mechanism against mitotic cell-death induced by BMI1 inhibition.

Gisler Santiago S   Maia Ana Rita R ARR   Chandrasekaran Gayathri G   Kopparam Jawahar J   van Lohuizen Maarten M  

PloS one 20200428 4


BMI1 is a core protein of the polycomb repressive complex 1 (PRC1) that is overexpressed in several cancer types, making it a promising target for cancer therapies. However, the underlying mechanisms and interactions associated with BMI1-induced tumorigenesis are often context-dependent and complex. Here, we performed a drug resistance screen on mutagenized human haploid HAP1 cells treated with BMI1 inhibitor PTC-318 to find new genetic and mechanistic features associated with BMI1-dependent can  ...[more]

Similar Datasets

| S-EPMC5474757 | biostudies-literature
| S-EPMC4865845 | biostudies-literature
| S-EPMC5520177 | biostudies-literature
| S-EPMC4195789 | biostudies-other
| S-EPMC9237198 | biostudies-literature
| S-EPMC5380511 | biostudies-literature
| S-EPMC7174303 | biostudies-literature
| S-EPMC9769698 | biostudies-literature
| S-EPMC7383499 | biostudies-literature
| S-EPMC6365652 | biostudies-literature